The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
<emph type="ital">Ginkgo biloba</emph> for Prevention of Dementia<subtitle>A Randomized Controlled Trial</subtitle>
Open accessAbstract
CONTEXT: Ginkgo biloba is widely used for its potential effects on memory and cognition. To date, adequately powered clinical trials testing the effect of G. biloba on dementia incidence are lacking. OBJECTIVE: To determine effectiveness of G. biloba vs placebo in reducing the incidence of all-cause dementia and Alzheimer disease (AD) in elderly individuals with normal cognition and those with mild cognitive impairment (MCI). DESIGN, SETTING, AND PARTICIPANTS: Randomized, double-blind, placebo-controlled clinical trial conducted in 5 academic medical centers in the United States between 2000 and 2008 with a median follow-up of 6.1 years. Three thousand sixty-nine community volunteers aged 75 years or older with normal cognition (n = 2587) or MCI (n = 482) at study entry were assessed every 6 months for incident dementia. INTERVENTION: Twice-daily dose of 120-mg extract of G. biloba (n = 1545) or placebo (n = 1524). MAIN OUTCOME MEASURES: Incident dementia and AD determined by expert panel consensus. RESULTS: Five hundred twenty-three individuals developed dementia (246 receiving placebo and 277 receiving G. biloba) with 92% of the dementia cases classified as possible or probable AD, or AD with evidence of vascular disease of the brain. Rates of dropout and loss to follow-up were low (6.3%), and the adverse effect profiles were similar for both groups. The overall dementia rate was 3.3 per 100 person-years in participants assigned to G. biloba and 2.9 per 100 person-years in the placebo group. The hazard ratio (HR) for G. biloba compared with placebo for all-cause dementia was 1.12 (95% confidence interval [CI], 0.94-1.33; P = .21) and for AD, 1.16 (95% CI, 0.97-1.39; P = .11). G. biloba also had no effect on the rate of progression to dementia in participants with MCI (HR, 1.13; 95% CI, 0.85-1.50; P = .39). CONCLUSIONS: In this study, G. biloba at 120 mg twice a day was not effective in reducing either the overall incidence rate of dementia or AD incidence in elderly individuals with normal cognition or those with MCI. Trial Registration clinicaltrials.gov Identifier: NCT00010803.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Psychological Assessment Resources
Abidin, R. R. (1995) · Medical Entomology and Zoology · Cited by 3,147
(1987) · PubMed · Cited by 2,657
The relation of the Trail Making Test to organic brain damage.
Reitan, R. M. (1955) · Journal of Consulting Psychology · doi:10.1037/h0044509 · Cited by 1,798
Brookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
Strauss, E., & Spreen, O. (2009) · Cited by 1,444
The Nitric Oxide-Scavenging Properties of Ginkgo Biloba Extract EGb 761
Marcocci, L., Maguire, J. J., Droylefaix, M. T., & Packer, L. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1764 · Cited by 1,048
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966
Guide to using the Coloured Progressive Matrices.
Raven, J. (1958) · Cited by 667
The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease
Oken, B. S., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Development and Validation of a Model for Estimating Premorbid Verbal Intelligence in the Elderly
Grober, E., Sliwinsk, M., & Korey, S. R. (1991) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639108405109 · Cited by 563
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A., Curry, K. J., Buford, J. P., Khan, I., Netzer, W. J., Xu, H., & Butko, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425199 · Cited by 398
Bastianetto, S., Ramassamy, C., Doré, S., Christen, Y., Poirier, J., & Quirion, R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00069.x · Cited by 379
Designs for group sequential tests
Fleming, T. R., Harrington, D. P., & O'Brien, P. C. (1984) · Controlled Clinical Trials · doi:10.1016/s0197-2456(84)80014-8 · Cited by 353
Agüero-Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M., von Strauss, E., & Winblad, B. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.10.1452 · Cited by 340
Chui, H. C., Mack, W., Jackson, J. E., Mungas, D., Reed, B. R., Tinklenberg, J., Chang, F.-L., Skinner, K., Tasaki, C., & Jagust, W. J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.191 · Cited by 250
Evaluation of Dementia in the Cardiovascular Health Cognition Study
Lopez, O. L., Kuller, L. H., Fitzpatrick, A., Ives, D., Becker, J. T., & Beauchamp, N. (2003) · Neuroepidemiology · doi:10.1159/000067110 · Cited by 237
Pietri, S., Maurelli, E., Drieu, K., & Culcasi, M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0316 · Cited by 235
Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type
Maurer, K., Ihl, R., Dierks, T., & Frölich, L. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00022-8 · Cited by 202
Neuropsychological characteristics of mild cognitive impairment subgroups
Lopez, O. L. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.045567 · Cited by 197
Schneider, L., DeKosky, S., Farlow, M., Tariot, P., Hoerr, R., & Kieser, M. (2005) · Current Alzheimer Research · doi:10.2174/156720505774932287 · Cited by 182
Self-citationDeKosky, S. T., Fitzpatrick, A., Ives, D. G., Saxton, J., Williamson, J., Lopez, O. L., Burke, G., Fried, L., Kuller, L. H., Robbins, J., et al. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.02.007 · Cited by 176
Self-citationA randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
Dodge, H. H., Zitzelberger, T., Oken, B., Howieson, D. B., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000303814.13509.db · Cited by 162
Normal Rates of Forgetting of Verbal and Non-Verbal Material in Alzheimer's Disease
Becker, J. T., Boller, F., Saxton, J. A., & McGonigle-Gibson, K. L. (1987) · Cortex · doi:10.1016/s0010-9452(87)80019-9 · Cited by 145
Clinical Criteria for Vascular Dementia: The NINDS-AIREN Criteria
Erkinjuntti, T. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106721 · Cited by 141
Ginkgo Biloba for the Prevention and Treatment of Cardiovascular Disease: A Review of the Literature
Mahady, G. B. (2002) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200207000-00004 · Cited by 136
Normative Data on the Boston Naming Test and Two Equivalent 30-Item Short Forms
Saxton, J. A., Ratcliff, G. G., Munro, C. A., Coffey, E. C., Becker, J. T., Fried, L. P., & Kuller, L. H. (2000) · The Clinical Neuropsychologist · doi:10.1076/clin.14.4.526.7204 · Cited by 134
Comprehensive and Neuropsychologic Evaluations
Mohs, R. C. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002578 · Cited by 106
Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W., & Hörr, R. (1997) · Phytomedicine · doi:10.1016/s0944-7113(97)80021-9 · Cited by 99
EXTRACTS OF GINKGO BILOBA AND GINSENOSIDES EXERT CEREBRAL VASORELAXATION VIA A NITRIC OXIDE PATHWAY
Chen, X., Salwinski, S., & Lee, T. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02727.x · Cited by 87
Rockwood, K. J., Parhad, I. M., Hachinski, V., Erkinjuntti, T., Rewcastle, B., Kertesz, A., Eastwood, M. R., & Phillips, S. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100040968 · Cited by 81
McCarney, R., Fisher, P., Iliffe, S., van Haselen, R. A., Griffin, M., van der Meulen, J., & Warner, J. P. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2055 · Cited by 81
Fitzpatrick, A. L., Fried, L. P., Williamson, J. D., Crowley, P., Posey, D., Kwong, L., Bonk, J., Moyer, R., Chabot, J., Kidoguchi, L., et al. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.06.007 · Cited by 80
Self-citationThe impact of disability in older women.
Guralnik, J. M., Leveille, S. G., Hirsch, R., Ferrucci, L., & Fried, L. P. (1997) · PubMed · Cited by 76
Underrecognition of Cognitive Impairment in Assisted Living Facilities
Magsi, H., & Malloy, T. R. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53117.x · Cited by 71
Vellas, B. J., Andrieu, S., Ousset, P., Ouzid, M., & Mathiex‐Fortunet, H. (2006) · Neurology · doi:10.1212/wnl.67.9_suppl_3.s6 · Cited by 68
Aging and the Public Health Effects of Dementia
Kawas, C. H., & Brookmeyer, R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441509 · Cited by 55
Effects of Ginkgo biloba on arterial smooth muscle responses to vasoactive stimuli
Auguet, M., DeFeudis, F. V., & Clostre, F. (1982) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(82)90075-1 · Cited by 32
Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study
Snitz, B. E., Saxton, J. A., López, O. L., Ives, D. G., Dunn, L. O., Rapp, S. R., Carlson, M. C., Fitzpatrick, A. L., DeKosky, S. T., & for the GEM study Investigators (2009) · Aging & Mental Health · doi:10.1080/13607860802380656 · Cited by 24
Self-citation
Cited by
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12191 · Cited by 651
Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals
van Beek, T. A., & Montoro, P. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.01.013 · Cited by 550
Metadata
- Authors
- DeKosky, S. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-11-19
- Volume
- 300
- Issue
- 19
- Pages
- 2253
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2152415998
- Cited by
- 670
- References
- 44
- FWCI
- 152.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.